SEC Tracker
Get the app

Sionna Therapeutics SION

RA Capital Healthcare Fund (Director) plans to sell 2,278 SION shares, about $89,115

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Nov 19, 2025
  2. Broker: BTIG, LLC
  3. Shares acquired by: Private Transaction

All of RA Capital Healthcare Fund's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 433 shares at $42.1 on Nov 17, 2025 · Form 4
  • Sold 331 shares at $42.1 on Nov 17, 2025 · Form 4
  • Sold 332 shares at $39.57 on Nov 18, 2025 · Form 4
  • Sold 150 shares at $39.89 on Nov 20, 2025 · Form 4
  • Sold 801 shares at $39.89 on Nov 20, 2025 · Form 4
  • Sold 96 shares at $40.5 on Nov 20, 2025 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Sionna Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Emergent BioSolutions EBS public float $343M, Jun 30, 2025
  2. Northwest Biotherapeutics NWBO public float $340M, Jun 30, 2025
  3. Amarin AMRN public float $335M, Jun 30, 2025
  4. Rigel Pharmaceuticals RIGL public float $332M, Jun 30, 2025
  5. Usana Health Sciences USNA public float $328M, Jun 27, 2025